Challenge study of the pathogen reduction capacity of the THERAFLEX MB‐Plasma technology

E-ISSN： 1423-0410|109|2|129-137

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.109, Iss.2, 2015-08, pp. : 129-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 2, 2009-03 ,pp. : 122-127

Karger

Access to resources Recommend Favorite

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 8-18

Karger

Access to resources Recommend Favorite

The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 65-70

Karger

Access to resources Recommend Favorite

UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 43-54

Karger

Access to resources Recommend Favorite